Contact Information
Company Information
Company
Amphista Therapeutics Limited
Annual Revenue
11000000.0
Technologies
NetSuite
Amazon SES
Sendgrid
Mimecast
Outlook
DigitalOcean
Active Campaign
Nginx
Bootstrap Framework
Mobile Friendly
Google Tag Manager
YouTube
WordPress.org
Keywords
targeted protein degradation
biology
chemistry
drug discovery
development
biotechnology research
tpd
targeted glues
protein degradation
therapeutics
biotechnology
cns
oncology
immuno-oncology
small molecule
therapeutic applications
medicine development
class-leading degraders
molecular mechanism
innovative therapies
preclinical development
clinical trials
ai & ml
computational modeling
bioinformatics
chemical properties
tissue targeting
patient impact
next generation therapy
pathogenic proteins
molecular biology
drug development
biopharmaceutical
advanced analytics
translational research
medicinal chemistry
innovative technologies
drug-like properties
in vivo studies
gene targeting
protein homeostasis
covalent drugs
synergistic approaches
novel chemistry
chemoinformatics
platform technology
biopharma ecosystem
therapeutic pipeline
phase progression
protein removal
high-content assays
targeted glue technology
transformational medicines
cancer therapeutics
neurodegenerative disorders
small molecule degraders
rationally designed molecules
protein degradation pathways
biopharmaceuticals
cns-penetrant drugs
disease-causing proteins
strategic collaborations
advanced drug development
proprietary technology
clinical validation
life sciences
funding
partnerships
patient outcomes
unmet medical needs
competitive landscape
intellectual property
commercial success
supportive culture
innovative thinking
hospital & health care
health care
health
wellness & fitness
information technology & services
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans